Ex parte CONLEY et al. - Page 5




                 Appeal No. 1997-3332                                                                                                                   
                 Application No. 08/436,182                                                                                                             


                          In viewing the claims in terms of obviousness, we                                                                             
                 recognize that appellants rely upon data presented in their                                                                            
                 specification (pages 16-18; Example II), and the Mazzola                                                                               
                 Declaration filed on Nov. 2, 1995, as evidence of                                                                                      
                 nonobviousness.  According to appellants and the Mazzola                                                                               
                 Declaration, this evidence demonstrates that a Neodol 23-3                                                                             
                 based surfactant blend contributes improved cold water residue                                                                         
                 properties to a carbonate-based laundry detergent in                                                                                   
                 comparison with a Neodol                                                                                                               
                 25-3 based surfactant blend as used in the working examples of                                                                         
                 the Mazzola patent.   However, appellants have failed to1                                                                                                    
                 explain how they arrived at that conclusion based on the data                                                                          
                 reported in their specification on page 18 (Example II).                                                                               
                 Appellants have the burden of explaining the relevance and                                                                             
                 significance of the data presented.  See In re Borkowski, 505                                                                          
                 F.2d 713, 719, 184 USPQ 29, 33 (CCPA 1974).                                                                                            
                          Appellants have failed to explain the relevance of the                                                                        
                 data upon which they rely.  As we see it, in comparative                                                                               

                          1According to appellants' specification (page 8 and 11),                                                                      
                 Neodol 23-3 is a mixture of ethoxylated C C  alcohols;                                                                                 
                                                                                           12- 13                                                       
                 whereas Neodol 25-3 is a mixture of ethoxylated C -C                                                                                   
                                                                                                         12    15                                       
                 alcohols.                                                                                                                              
                                                                           5                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007